{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:15:13Z","timestamp":1788243313154,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe community-acquired pneumonia (SCAP) is associated with high mortality and substantial heterogeneity in host immune responses among critically ill patients. Conventional prognostic scores primarily reflect comorbidity burden and organ dysfunction but do not directly capture immune dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 223 critically ill patients with SCAP admitted to the respiratory intensive care unit (RICU). Six prespecified immune-inflammatory biomarkers were evaluated as candidate predictors. The Immune-Inflammatory Dysregulation Score (IIDS) was developed using bootstrap-based stability selection (1,000 bootstrap resamples) followed by multivariable logistic regression. The discriminative performance of IIDS was compared with conventional clinical severity scores, and its incremental prognostic value was assessed using sequential prediction models. A final prediction model incorporating IIDS was internally evaluated using bootstrap optimism correction and presented as a nomogram.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IIDS comprised CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell count, monocyte count, and the neutrophil-to-lymphocyte ratio. IIDS showed moderate apparent discrimination for 28-day mortality (AUC: 0.721; 95% CI: 0.654\u20130.787). Adding IIDS to the CCI\u2009+\u2009SOFA model increased the apparent AUC from 0.773 to 0.819 (DeLong\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014) and the bootstrap optimism-corrected AUC from 0.767 to 0.809. Optimism-corrected reclassification estimates were imprecise, with confidence intervals for NRI and IDI including zero. The final model showed close agreement between predicted and observed risks after optimism correction and provided potential net clinical benefit across the evaluated threshold-probability range.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IIDS provided prognostic information complementary to conventional clinical predictors and improved apparent discrimination when incorporated into a sequential prediction model. Independent external validation is required before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1923412","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:35:54Z","timestamp":1788240954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An immune-inflammatory dysregulation score for risk stratification of 28-day all-cause mortality in critically ill patients with severe community-acquired pneumonia"],"prefix":"10.3389","volume":"13","author":[{"given":"Shulan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American thoracic society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"EVIDoa2500244","DOI":"10.1056\/EVIDoa2500244","article-title":"Outcomes of pneumonia in ICUs in low- and middle-income countries: a systematic review","volume":"5","author":"Pitrowsky","year":"2026","journal-title":"NEJM Evid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ebiom.2017.09.023","article-title":"Lymphopenic community acquired pneumonia (L-CAP), an immunological phenotype associated with higher risk of mortality","volume":"24","author":"Bermejo-Martin","year":"2017","journal-title":"EBioMedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jinf.2019.04.006","article-title":"Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality","volume":"78","author":"M\u00e9ndez","year":"2019","journal-title":"J Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/jcm8050754","article-title":"Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock","volume":"8","author":"G\u00fcell","year":"2019","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"106131","DOI":"10.1016\/j.jinf.2024.106131","article-title":"Lymphopenia is associated with broad host response aberrations in community-acquired pneumonia","volume":"88","author":"Doeleman","year":"2024","journal-title":"J Infect"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1164\/rccm.202501-0217OC","article-title":"A large-scale single-cell atlas reveals the peripheral immune panorama of bacterial pneumonia","volume":"211","author":"Xiao","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s15010-023-01992-2","article-title":"The ratio of neutrophil-to-lymphocyte and platelet-to-lymphocyte and association with mortality in community-acquired pneumonia: a derivation-validation cohort study","volume":"51","author":"Enersen","year":"2023","journal-title":"Infection"},{"key":"B15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/biomedicines12020260","article-title":"The neutrophil\/lymphocyte ratio and outcomes in hospitalized patients with community-acquired pneumonia: a retrospective cohort study","volume":"12","author":"Tekin","year":"2024","journal-title":"Biomedicines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.clinme.2024.100278","article-title":"The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumonia","volume":"25","author":"Sharma","year":"2025","journal-title":"Clin Med (Lond)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2213-2600(25)00429-1","article-title":"Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial","volume":"14","author":"Michels","year":"2026","journal-title":"Lancet Respir Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.21037\/jtd-2024-2081","article-title":"Comorbidities and their impact on in-hospital mortality in hospitalized adult patients with bacterial community-acquired pneumonia: a cohort study","volume":"17","author":"Cheng","year":"2025","journal-title":"J Thorac Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.21037\/jtd-2026-0531","article-title":"Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia in the intensive care unit","volume":"18","author":"Zhang","year":"2026","journal-title":"J Thorac Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1136\/thx.2009.133280","article-title":"Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia: systematic review and meta-analysis","volume":"65","author":"Chalmers","year":"2010","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/cc11447","article-title":"Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis","volume":"16","author":"Marti","year":"2012","journal-title":"Crit Care"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1923412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:35:54Z","timestamp":1788240954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1923412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1923412"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1923412","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1923412"}}